Valuation

PRMDPromed

StockMoscow ExchangeRusyaHealth care
4/10

Ratios vs sector

Medians of Health care companies worldwide (too few in the region).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricPRMDSector medianvs median
P/E—28,5 · n=122—
P/B—3,0 · n=210—
P/S—3,7 · n=213—
EV/EBIT—23,8 · n=110—
Free-cash-flow yield—%2,8 · n=199—
Dividend yield%1,99%0,00 · n=282—
Return on equity—%2,7 · n=207—
Return on invested capital—%3,7 · n=187—
Gross margin—%62,5 · n=160—
Net debt / EBITDA—1,14 · n=112—

Value factor: 7 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

InstrumentP/EP/BEV/EBITFree-cash-flow yieldDividend yieldSmart Score
LLYEli Lilly & Co42,633,6—%1,6%0,66/10
JNJJohnson & Johnson29,17,2—%3,6%2,18/10
ABBVAbbVie79,9—33,5%3,6%3,05/10
MRKMerck114,68,7—%4,4%2,38/10
UNHUnitedHealth25,13,418,6%6,7%2,39/10
NVSNovartis AG20,06,116,9%6,3%3,210/10
TMOThermo Fisher Scientific35,74,735,2%2,9%0,38/10
AMGNAmgen26,319,724,0%4,4%2,36/10
GILDGILEAD—16,1—%6,8%2,14/10
ABTAbbott28,53,426,8%4,1%3,05/10

ratios computed by AI-Stock Invest from public filings and end-of-day prices